Tetraspanin markers are commonly used to identify EVs and we previously demonstrated that the number and proportion of CD63+ circulating plasma EVs is significantly elevated in patients with glioblastomas and anaplastic astrocytomas, with a similar trend for CD81+ EVs [10]. Here, CD63 is linked to glioblastoma.